Literature DB >> 12450378

Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.

Kristen Sadler1, Khee Dong Eom, Jin-Long Yang, Yoana Dimitrova, James P Tam.   

Abstract

The intracellular delivery of most peptides, proteins, and nucleotides to the cytoplasm and nucleus is impeded by the cell membrane. To allow simplified, noninvasive delivery of attached cargo, cell-permeant peptides that are either highly cationic or hydrophobic have been utilized. Because cell-permeable peptides share half of the structural features of antimicrobial peptides containing clusters of charge and hydrophobic residues, we have explored antimicrobial peptides as templates for designing cell-permeant peptides. We prepared synthetic fragments of Bac 7, an antimicrobial peptide with four 14-residue repeats from the bactenecin family. The dual functions of cell permeability and antimicrobial activity of Bac 7 were colocalized at the N-terminal 24 residues of Bac 7. In general, long fragments of Bac(1-24) containing both regions were bactericidal and cell-permeable, whereas short fragments with only a cationic or hydrophobic region were cell-permeant without the attendant microbicidal activity when measured in a fluorescence quantitation assay and by confocal microscopy. In addition, the highly cationic fragments were capable of traversing the cell membrane and residing within the nucleus. A common characteristic shared by the cell-permeant Bac(1-24) fragments, irrespective of their number of charged cationic amino acids, is their high proline content. A 10-residue proline-rich peptide with two arginine residues was capable of delivering a noncovalently linked protein into cells. Thus, the proline-rich peptides represent a potentially new class of cell-permeant peptides for intracellular delivery of protein cargo. Furthermore, our results suggest that antimicrobial peptides may represent a rich source of templates for designing cell-permeant peptides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12450378     DOI: 10.1021/bi026661l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  39 in total

1.  In vivo significance of ITK-SLP-76 interaction in cytokine production.

Authors:  Juris A Grasis; David M Guimond; Nicholas R Cam; Krystal Herman; Paola Magotti; John D Lambris; Constantine D Tsoukas
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

2.  Antimicrobial activity and bacterial-membrane interaction of ovine-derived cathelicidins.

Authors:  Rachel C Anderson; Robert E W Hancock; Pak-Lam Yu
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

3.  Colorectal delivery and retention of PEG-Amprenavir-Bac7 nanoconjugates--proof of concept for HIV mucosal pre-exposure prophylaxis.

Authors:  Mahta Samizadeh; Xiaoping Zhang; Simi Gunaseelan; Antoinette G Nelson; Matthew S Palombo; Daniel R Myers; Yashveer Singh; Usha Ganapathi; Zoltan Szekely; Patrick J Sinko
Journal:  Drug Deliv Transl Res       Date:  2016-02       Impact factor: 4.617

Review 4.  Cell-penetrating peptides and antimicrobial peptides: how different are they?

Authors:  Sónia Troeira Henriques; Manuel Nuno Melo; Miguel A R B Castanho
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

Review 5.  Designing protein-based biomaterials for medical applications.

Authors:  Jennifer E Gagner; Wookhyun Kim; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

Review 6.  Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.

Authors:  Gene L Bidwell; Drazen Raucher
Journal:  Adv Drug Deliv Rev       Date:  2010-05-15       Impact factor: 15.470

Review 7.  Antimicrobial peptides with cell-penetrating peptide properties and vice versa.

Authors:  Katrin Splith; Ines Neundorf
Journal:  Eur Biophys J       Date:  2011-02-19       Impact factor: 1.733

Review 8.  Diversity in penaeidin antimicrobial peptide form and function.

Authors:  Brandon J Cuthbertson; Leesa J Deterding; Jason G Williams; Kenneth B Tomer; Kizee Etienne; Perry J Blackshear; Erika E Büllesbach; Paul S Gross
Journal:  Dev Comp Immunol       Date:  2007-08-03       Impact factor: 3.636

Review 9.  Anti-cancer therapies that utilize cell penetrating peptides.

Authors:  Benjamin G Bitler; Joyce A Schroeder
Journal:  Recent Pat Anticancer Drug Discov       Date:  2010-06       Impact factor: 4.169

10.  The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection.

Authors:  Monica Benincasa; Chiara Pelillo; Sonia Zorzet; Chiara Garrovo; Stefania Biffi; Renato Gennaro; Marco Scocchi
Journal:  BMC Microbiol       Date:  2010-06-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.